ArticleJournal of breast cancer2021

Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Jee Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.